American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition (Q34767892)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition |
scientific article |
Statements
1 reference
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition (English)
1 reference
Harold J Burstein
1 reference
Isaac Lipkus
1 reference
Eric P Winer
1 reference
Rowan T Chlebowski
1 reference
Nananda Col
1 reference
Deborah E Collyar
1 reference
Steven R Cummings
1 reference
Victor G Vogel
1 reference
Andrea Eisen
1 reference
David G Pfister
1 reference
American Society of Clinical Oncology Breast Cancer Technology Assessment Working Group
1 reference
1 August 2002
1 reference
1 reference
Identifiers
1 reference